259 research outputs found
Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy
<b>Background:</b>
Androgen-deprivation therapy (ADT) is standard treatment for locally advanced or metastatic prostate cancer (PCa). Many patients develop castration resistance (castration-resistant PCa [CRPC]) after approximately 2â3 yr, with a poor prognosis. The molecular mechanisms underlying CRPC progression are unclear.<p></p>
<b>Objective:</b>
To undertake quantitative tumour transcriptome profiling prior to and following ADT to identify functionally important androgen-regulated pathways or genes that may be reactivated in CRPC.<p></p>
<b>Design, setting, and participants:</b>
RNA sequencing (RNA-seq) was performed on tumour-rich, targeted prostatic biopsies from seven patients with locally advanced or metastatic PCa before and approximately 22 wk after ADT initiation. Differentially regulated genes were identified in treatment pairs and further investigated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) on cell lines and immunohistochemistry on a separate CRPC patient cohort. Functional assays were used to determine the effect of pathway modulation on cell phenotypes.<p></p>
<b>Outcome measurements and statistical analysis:</b>
We searched for gene expression changes affecting key cell signalling pathways that may be targeted as proof of principle in a CRPC in vitro cell line model.<p></p>
<b>Results and limitations:</b>
We identified ADT-regulated signalling pathways, including the Wnt/β-catenin signalling pathway, and observed overexpression of β-catenin in a subset of CRPC by immunohistochemistry. We validated 6 of 12 (50%) pathway members by qRT-PCR on LNCaP/LNCaP-AI cell RNAs, of which 4 (67%) demonstrated expression changes consistent with RNA-seq data. We show that the tankyrase inhibitor XAV939 (which promotes β-catenin degradation) reduced androgen-independent LNCaP-AI cell line growth compared with androgen-responsive LNCaP cells via an accumulation of cell proportions in the G0/G1 phase and reduction in the S and G2/M phases. Our biopsy protocol did not account for tumour heterogeneity, and pathway inhibition was limited to pharmacologic approaches.<p></p>
<b>Conclusions:</b>
RNA-seq of paired PCa samples revealed ADT-regulated signalling pathways. Proof-of-principle inhibition of the Wnt/β-catenin signalling pathway specifically delays androgen-independent PCa cell cycle progression and proliferation and warrants further investigation as a potential target for therapy for CRPC.<p></p>
mTORC2 signaling drives the development and progression of pancreatic cancer
mTOR signaling controls several critical cellular functions and is deregulated in many cancers, including pancreatic cancer. To date, most efforts have focused on inhibiting the mTORC1 complex. However, clinical trials of mTORC1 inhibitors in pancreatic cancer have failed, raising questions about this therapeutic approach. We employed a genetic approach to delete the obligate mTORC2 subunit Rictor and identified the critical times during which tumorigenesis requires mTORC2 signaling. Rictor deletion resulted in profoundly delayed tumorigenesis. Whereas previous studies showed most pancreatic tumors were insensitive to rapamycin, treatment with a dual mTORC1/2 inhibitor strongly suppressed tumorigenesis. In late-stage tumor-bearing mice, combined mTORC1/2 and PI3K inhibition significantly increased survival. Thus, targeting mTOR may be a potential therapeutic strategy in pancreatic cancer
The CTLA-4 immune checkpoint protein regulates PD-L1:PD-1 interaction via transendocytosis of its ligand CD80
CTLA-4 and PD-1 are key immune checkpoint receptors that are targeted in the treatment of cancer. A recently identified physical interaction between the respective ligands, CD80 and PD-L1, has been shown to block PD-L1/PD-1 binding and to prevent PD-L1 inhibitory functions. Since CTLA-4 is known to capture and degrade its ligands via transendocytosis, we investigated the interplay between CD80 transendocytosis and CD80/PD-L1 interaction. We find that transendocytosis of CD80 results in a time-dependent recovery of PD-L1 availability that correlates with CD80 removal. Moreover, CD80 transendocytosis is highly specific in that only CD80 is internalised, while its heterodimeric PD-L1 partner remains on the plasma membrane of the antigen-presenting cell (APC). CTLA-4 interactions with CD80 do not appear to be inhibited by PD-L1, but efficient removal of CD80 requires an intact CTLA-4 cytoplasmic domain, distinguishing this process from more general trogocytosis and simple CTLA-4 binding to CD80/PD-L1 complexes. These data are consistent with CTLA-4 acting as modulator of PD-L1:PD-1 interactions via control of CD80
Direct Contacts of K+ Ions in the Selectivity Filter Enable the High Conductance of K+ Channels
Low-level Hypermutation in T Cellâindependent Germinal Centers Compared with High Mutation Rates Associated with T Cellâdependent Germinal Centers
Exceptionally germinal center formation can be induced without T cell help by polysaccharide-based antigens, but these germinal centers involute by massive B cell apoptosis at the time centrocyte selection starts. This study investigates whether B cells in germinal centers induced by the T cellâindependent antigen (4-hydroxy-3-nitrophenyl)acetyl (NP) conjugated to Ficoll undergo hypermutation in their immunoglobulin V region genes. Positive controls are provided by comparing germinal centers at the same stage of development in carrier-primed mice immunized with a T cellâdependent antigen: NP protein conjugate. False positive results from background germinal centers and false negatives from non-B cells in germinal centers were avoided by transferring B cells with a transgenic B cell receptor into congenic controls not carrying the transgene. By 4 d after immunization, hypermutation was well advanced in the T cellâdependent germinal centers. By contrast, the mutation rate for T cellâindependent germinal centers was low, but significantly higher than in NP-specific B cells from nonimmunized transgenic mice. Interestingly, a similar rate of mutation was seen in extrafollicular plasma cells at this stage. It is concluded that efficient activation of hypermutation depends on interaction with T cells, but some hypermutation may be induced without such signals, even outside germinal centers
Absorption-Line Probes of Gas and Dust in Galactic Superwinds
We discuss moderate resolution spectra of the NaD absorption-line in a sample
of 32 far-IR-bright starburst galaxies. In 18 cases, the line is produced
primarily by interstellar gas, and in 12 of these it is blueshifted by over 100
km/s relative to the galaxy systemic velocity. The absorption-line profiles in
these outflow sources span the range from near the galaxy systemic velocity to
a maximum blueshift of 400 to 600 km/s. The outflows occur in galaxies
systematically viewed more nearly face-on than the others. We therefore argue
that the absorbing material consists of ambient interstellar gas accelerated
along the minor axis of the galaxy by a hot starburst-driven superwind. The NaD
lines are optically-thick, but indirect arguments imply total Hydrogen column
densities of N_H = few X 10^{21} cm^{-2}. This implies that the superwind is
expelling matter at a rate comparable to the star-formation rate. This
outflowing material is very dusty: we find a strong correlation between the
depth of the NaD profile and the line-of-sight reddening (E(B-V) = 0.3 to 1
over regions several-to-ten kpc in size). The estimated terminal velocities of
superwinds inferred from these data and extant X-ray data are typically 400 to
800 km/s, are independent of the galaxy rotation speed, and are comparable to
(substantially exceed) the escape velocities for (dwarf) galaxies. The
resulting loss of metals can establish the mass-metallicity relation in
spheroids, produce the observed metallicity in the ICM, and enrich a general
IGM to 10 solar metallicity. If the outflowing dust grains survive their
journey into the IGM, their effect on observations of cosmologically-distant
objects is significant.Comment: 65 pages, including 16 figures. ApJ, in pres
Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodies
Anti-CTLA-4 antibodies have successfully elicited durable tumor regression in the clinic; however, long-term benefit is limited to a subset of patients for select cancer indications. The incomplete understanding of their mechanism of action has hindered efforts at improvement, with conflicting hypotheses proposing either antagonism of the CTLA-4:B7 axis or Fc effector-mediated regulatory T cell (Treg) depletion governing efficacy. Here, we report the engineering of a nonantagonistic CTLA-4 binding domain (b1s1e2) that depletes intratumoral Tregs as an Fc fusion. Comparison of b1s1e2-Fc to 9d9, an antagonistic anti-CTLA-4 antibody, allowed for interrogation of the separate contributions of CTLA-4 antagonism and Treg depletion to efficacy. Despite equivalent levels of intratumoral Treg depletion, 9d9 achieved more long-term cures than b1s1e2-Fc in MC38 tumors, demonstrating that CTLA-4 antagonism provided additional survival benefit. Consistent with prior reports that CTLA-4 antagonism enhances priming, treatment with 9d9, but not b1s1e2-Fc, increased the percentage of activated T cells in the tumor-draining lymph node (tdLN). Treg depletion with either construct was restricted to the tumor due to insufficient surface CTLA-4 expression on Tregs in other compartments. Through intratumoral administration of diphtheria toxin in Foxp3-DTR mice, we show that depletion of both intratumoral and nodal Tregs provided even greater survival benefit than 9d9, consistent with Treg-driven restraint of priming in the tdLN. Our data demonstrate that anti-CTLA-4 therapies require both CTLA-4 antagonism and intratumoral Treg depletion for maximum efficacy-but that potential future therapies also capable of depleting nodal Tregs could show efficacy in the absence of CTLA-4 antagonism
Loss of N-WASP drives early progression in an Apc model of intestinal tumourigenesis
NâWASP (WASL) is a widely expressed cytoskeletal signalling and scaffold protein also implicated in regulation of Wnt signalling and homeostatic maintenance of skin epithelial architecture. NâWASP mediates invasion of cancer cells in vitro and its depletion reduces invasion and metastatic dissemination of breast cancer. Given this role in cancer invasion and universal expression in the gastrointestinal tract, we explored a role for NâWASP in the initiation and progression of colorectal cancer. While deletion of Nâwasp is not detectably harmful in the murine intestinal tract, numbers of Paneth cells increased, indicating potential changes in the stem cell niche and migration up the cryptâvillus axis was enhanced. Loss of Nâwasp promoted adenoma formation in an adenomatous polyposis coli (Apc) deletion model of intestinal tumourigenesis. Thus, we establish a tumour suppressive role of NâWASP in early intestinal carcinogenesis despite its later proâinvasive role in other cancers. Our study highlights that while the actin cytoskeletal machinery promotes invasion of cancer cells, it also maintains normal epithelial tissue function and thus may have tumour suppressive roles in preâneoplastic tissues
ALMA observations of massive molecular gas reservoirs in dusty early-type galaxies
Unresolved gas and dust observations show a surprising diversity in the amount of interstellar matter in early-type galaxies. Using ALMA observations we resolve the ISM in zâź0.05 early-type galaxies. From a large sample of early-type galaxies detected in the Herschel Astrophysical Terahertz Large Area Survey (H-ATLAS) we selected five of the dustiest cases, with dust masses Md âźseveralĂ 107Mâ, with the aim of mapping their submillimetre continuum and 12CO(2-1) line emission distributions. These observations reveal molecular gas disks. There is a lack of associated, extended continuum emission in these ALMA observations, most likely because it is resolved out or surface brightness limited, if the dust distribution is as extended as the CO gas. However, two galaxies have central continuum ALMA detections. An additional, slightly offset, continuum source is revealed in one case, which may have contributed to confusion in the Herschel fluxes. Serendipitous continuum detections further away in the ALMA field are found in another case. Large and massive rotating molecular gas disks are mapped in three of our targets, reaching a fewĂ 109Mâ. One of these shows evidence of kinematic deviations from a pure rotating disc. The fields of our two remaining targets contain only smaller, weak CO sources, slightly offset from the optical galaxy centres. These may be companion galaxies seen in ALMA observations, or background objects. These heterogeneous findings in a small sample of dusty early-type galaxies reveal the need for more such high spatial resolution studies, to understand statistically how dust and gas are related in early-type galaxies
Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer.
Different thresholds of Wnt signalling are thought to drive stem cell maintenance, regeneration, differentiation and cancer. However, the principle that oncogenic Wnt signalling could be specifically targeted remains controversial. Here we examine the requirement of BCL9/9l, constituents of the Wnt-enhanceosome, for intestinal transformation following loss of the tumour suppressor APC. Although required for Lgr5+ intestinal stem cells and regeneration, Bcl9/9l deletion has no impact upon normal intestinal homeostasis. Loss of BCL9/9l suppressed many features of acute APC loss and subsequent Wnt pathway deregulation in vivo. This resulted in a level of Wnt pathway activation that favoured tumour initiation in the proximal small intestine (SI) and blocked tumour growth in the colon. Furthermore, Bcl9/9l deletion completely abrogated β-catenin driven intestinal and hepatocellular transformation. We speculate these results support the just-right hypothesis of Wnt-driven tumour formation. Importantly, loss of BCL9/9l is particularly effective at blocking colonic tumourigenesis and mutations that most resemble those that occur in human cancer
- âŚ